Glut4 Antibodies

Santa Cruz Biotechnology provides a broad selection of Glut4 monoclonal antibodies for research in glucose transport and metabolism. Glut4 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glut4, or glucose transporter type 4, plays a central role in insulin-regulated glucose uptake in adipose tissues and muscle cells, maintaining glucose homeostasis. Dysregulation of Glut4 is associated with metabolic disorders, including type 2 diabetes and obesity, making it a significant focus in both basic and clinical research. Understanding the function and regulation of Glut4 can provide insights into therapeutic strategies for metabolic conditions. Researchers can investigate glucose transport mechanisms using specific molecular markers and advanced detection methods. Detailed characterization of Glut4 expression patterns helps reveal its role in cellular metabolism and disease progression. Current studies focusing on Glut4 continue to uncover new aspects of glucose regulation and metabolic pathways. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing our understanding of glucose transport and metabolic disease mechanisms.